A Message From Your Friends At The Southeast AETC: Our hearts go out to those in our community who were affected by the hurricanes. If you have patients that are having trouble accessing HIV services during this time, we urge you to utilize HRSA’s Find a Ryan White Provider tool to help navigate them to services nearby.

Webinar: Outpatient OUD Treatment

Primary Care & Comorbidities, Webcast

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides

Facilitated by Michael Baca-Atlas, MD, FASAM
Clinical Assistant Professor
UNC Department of Family Medicine
UNC WakeBrook Primary Care
December 2, 2020

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides

Facilitated by Michael Baca-Atlas, MD, FASAM
Clinical Assistant Professor
UNC Department of Family Medicine
UNC WakeBrook Primary Care
December 2, 2020

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides